bullish
Aier Eye Hospital(300015.CH) - The Largest Ophthalmic Chain in China with Promising Growth Potential
271 Views09 Dec 2020 09:30
This article analyzed China's largest ophthalmic chain Aier Eye Hospital in terms of market potential, development mode, financial position and made forecast and rating for the company.
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
Price Chart(Sign Up to Access)
- Pre-IPO MicroPort CardioFlow - A Better Candidate of the TAVR Market in China?16 Dec 2020
- JD Health (6618.HK) - Opportunities Coexist with Challenges15 Dec 2020
- Industry Report - Investment Opportunity in China Retail Pharmacy Market10 Dec 2020
- Pre-IPO Harbour Biomed (2142.HK) - Don't Ignore The "Hidden Value"01 Dec 2020
- 2021 High Conviction - Investment Opportunities in China Healthcare Industry23 Nov 2020
- Pre-IPO JD Health (JDH.HK) - A Better Candidate of Online Healthcare Business In China?15 Oct 2020
x